Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus

Journal of Korean Medical Science

Volumn 24, Issue SUPPL.1, 2009, Pages

  Kim, Yong Kyun ^a   Lee, Jung Eun ^b   Kim, Yoon Goo ^b   Kim, Dae Joong ^b   Oh, Ha Young ^b   Yang, Chul Woo ^a   Kim, Kwang Won ^b   Huh, Wooseong ^b  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Glomerular filtration rate; Type 2

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE; DEGENERATIVE DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART RATE; HUMAN; KIDNEY; KIDNEY DISEASE; MALE; METHODOLOGY; MIDDLE AGED; NEPHROLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

AGED; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART DISEASES; HEART RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROLOGY; NEURODEGENERATIVE DISEASES;

EID: 62449213632     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S69     Document Type: Article

References (24)

1. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000; 49: 1399-408.
2. Caramori ML, Fioretto P, Mauer M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol 2006; 17: 339-52.
3. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetic Care 2003; 26: 1553-79.
4. Duvnjak L, Vuckovic S, Car N, Metelko Z. Relationship between autonomic function, 24-h blood pressure, and albuminuria in normotensive, normoalbuminuric patients with type 1 diabetes. J Diabetes Complications 2001; 15: 314-9.
5. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993; 16: 773-9.
6. Forsen A, Kangro M, Sterner G, Norrgren K, Thorsson O, Wollmer P, Sundkvist G. A 14-year prospective study of autonomic nerve function in type 1 diabetic patients: association with nephropathy. Diabet Med 2004; 21: 852-8.
7. Weinrauch LA, Kennedy FP, Gleason RE, Keough J, D'Elia JA. Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control. Am J Hypertens 1998; 11: 302-8.
8. Burger AJ, D'Elia JA, Weinrauch LA, Lerman I, Gaur A. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. Int J Cardiol 2002; 86: 281-7.
9. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiac autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications 2000; 14: 1-6.
10. Clarke CF, Eason M, Reilly A, Boyce D, Werther GA. Autonomic nerve function in adolescents with type 1 diabetes mellitus: relationship to microalbuminuria. Diabet Med 1999; 16: 550-4.
11. Pecis M, Azevedo MJ, Moraes RS, Ferlin EL, Gross JL. Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care 2000; 23: 989-93.
12. Molgaard H, Christensen PD, Sorensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992; 41: 812-7.
13. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77: 75-197.
14. Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003; 14: 3239-44.
15. Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normalbuminuric range in IDDM patients. Diabetologia 1997; 40: 718-25.
16. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994; 17: 578-84.
17. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-8.
18. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 1087-92.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
20. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55: 1832-9.
21. Istenes I, Keresztes K, Hermanyi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P. Relationship between autonomic neuropathy and hypertension--are we underestimating the problem? Diabet Med 2008; 25: 863-66.
22. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-51.
23. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.
24. Takayama S, Sakura H, Katsumori K, Wasada T, Iwamoto Y. A possible involvement of parasympathetic neuropathy on insulin resistance in patients with type 2 diabetes. Diabetes Care 2001; 24: 968-9.